Cliff Molife

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi request reprint Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations
    Cliff Molife
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA
    Postgrad Med 124:7-22. 2012
  2. doi request reprint Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe
    Cliff Molife
    Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN 46285, USA
    Diabetes Technol Ther 11:529-38. 2009

Detail Information

Publications2

  1. doi request reprint Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations
    Cliff Molife
    Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA
    Postgrad Med 124:7-22. 2012
    ..Little is known about the current prevalence and predictors of combination therapy. This analysis describes ADHD medication use focusing on combination versus monotherapy...
  2. doi request reprint Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe
    Cliff Molife
    Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, IN 46285, USA
    Diabetes Technol Ther 11:529-38. 2009
    ..These findings have potential clinical and policy implications for patients, diabetes care providers, and/or payers to make evidence-based decisions regarding ways to facilitate initiation and management of insulin therapy...